Clinical Trials Directory

Trials / Unknown

UnknownNCT02394262

Sequential Coronary CT-angiography and Biomarkers

Prediction of Atherosclerotic Plaque Burden Progression With Sequential Coronary CT-angiography and Biomarkers

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
140 (estimated)
Sponsor
Maastricht University Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Currently, cardiac computed tomography angiography (CCTA) is a well-implemented non-invasive diagnostic imaging modality in patients with stable chest pain. Besides conventional CT-reading, CCTA is also capable to identify several morphologic and geometric characteristics of atherosclerotic plaques. Recently, the investigators showed that the use of semi-automated plaque quantification algorithm identified parameters predictive for acute coronary syndrome on top of clinical risk profiling and conventional CT-reading. In addition, several atherotrombosis biomarkers, like high-sensitivity cardiac troponins, are described as related to coronary artery disease and cardiovascular events. Prospective data with sequential analysis of atherosclerotic plaques combined with different atherothrombosis biomarkers are currently lacking, but will provide important clues about the pathophysiology of plaque progression and atherothrombosis.

Conditions

Interventions

TypeNameDescription
RADIATIONCoronary CT-angiographySequential CCTA after one year follow-up. The first CCTA will be performed in terms of diagnostic work-up (referral outpatient Cardiology department).
OTHERAssesment of biomarkers involved in atherothrombosisSequential assesment of atherothrombis biomarkers: baseline and at 1 year follow-up.

Timeline

Start date
2015-03-01
Primary completion
2018-11-01
Completion
2019-11-01
First posted
2015-03-20
Last updated
2017-03-28

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT02394262. Inclusion in this directory is not an endorsement.